Organogenesis Holdings Inc Class A (ORGO) financials
Organogenesis revenue and earnings by year
Organogenesis's revenue was $564 million in the fiscal year to December 31, 2025, up 17.0% from the year before. Net income was $37.0 million, 6.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 16.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 564 | 482 | 433 | 451 | 467 | 338 | 261 | 193 | 199 | 139 |
| Revenue growth | 17.0% | 11.3% | -3.9% | -3.5% | 38.2% | 29.6% | 34.9% | -2.5% | 43.1% | — |
| Gross profit | 427 | 366 | 327 | 346 | 353 | 251 | 185 | 125 | 137 | 91 |
| Gross margin | 75.6% | 76.0% | 75.4% | 76.7% | 75.6% | 74.2% | 70.9% | 64.4% | 69.2% | 65.3% |
| Operating income | 45 | -1 | 13 | 22 | 72 | 27 | -30 | -48 | -6 | -9 |
| Operating margin | 7.9% | -0.3% | 2.9% | 4.9% | 15.5% | 7.9% | -11.4% | -24.8% | -2.8% | -6.3% |
| Net income | 37 | 1 | 5 | 16 | 94 | 17 | -39 | -65 | -8 | -17 |
| Net margin | 6.6% | 0.2% | 1.1% | 3.4% | 20.2% | 5.1% | -14.8% | -33.5% | -4.2% | -12.2% |
| Diluted EPS | $0.15 | -$0.01 | $0.04 | $0.12 | $0.70 | $0.15 | -$0.42 | -$0.95 | -$0.13 | — |
| Free cash flow | -24 | 4 | 7 | -9 | 31 | -12 | -40 | -62 | -6 | -6 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ORGO in Markets.
How Organogenesis makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Product | $42.8M | 97.8% |
| Grant | $950K | 2.2% |
See also: ORGO valuation and P/E history · ORGO returns
No forecast, no recommendation. This page describes Organogenesis Holdings Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.